Andrew R. Dunstan

Bradyzide, a potent non‐peptide B₂ bradykinin receptor antagonist with long‐lasting oral activity in animal models of inflammatory hyperalgesia

Gillian M. Burgess, Martin Perkins, H P Rang et al. · British Journal of Pharmacology · 2000 · 104 citations · Full text

Camostat Attenuates Airway Epithelial Sodium Channel Function in Vivo through the Inhibition of a Channel-Activating Protease

K. Coote, Hazel C. Atherton-Watson, Rosemary Sugar et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 93 citations

The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold

Edward K. Dziadulewicz, Michael C. Brown, Andrew R. Dunstan et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 57 citations · Full text

Biochemistry, Medicine, Peptide Library +8

1-(2-Nitrophenyl)thiosemicarbazides:  A Novel Class of Potent, Orally Active Non-Peptide Antagonist for the Bradykinin B₂ Receptor

Edward K. Dziadulewicz, Timothy J. Ritchie, Allan Hallett et al. · Journal of Medicinal Chemistry · 2000 · 26 citations · Full text

Altmetric Attention Score, Peptide Science, Pharmacotherapy +17

8-Aryl xanthines potent inhibitors of phosphodiesterase 5

Ruth Arnold, David Beer, Gurdip Bhalay et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 23 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +7